# A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function

> **NCT05283746** · PHASE1 · COMPLETED · sponsor: **AN2 Therapeutics, Inc** · enrollment: 40 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** Epetraborole

## Key facts

- **NCT ID:** NCT05283746
- **Lead sponsor:** AN2 Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-21
- **Primary completion:** 2022-06-10
- **Final completion:** 2022-06-27
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05283746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05283746, "A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05283746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*